Skip to content

BG Proximal Femur

by Howmedica Corp.

510(k) K790274

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK790274 Date26 Mar 1979ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JDL
Device Class
Class III
Regulation
21 CFR Part 888.3320
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The BG Proximal Femur is a semi-constrained metal cemented acetabular component for hip prostheses, designed to replace the femoral head and acetabulum in total hip arthroplasty. It is intended for use in orthopedic surgical procedures to restore function and alleviate pain in patients with degenerative joint disease or hip fractures.

This device is supplied as a reusable surgical implant and is regulated under FDA 510(k) clearance (K790274) as a Class III medical device. It is classified under product code JDL and adheres to regulation 888.3320, with a decision of Substantially Equivalent (SESE). The BG Proximal Femur is intended for use in sterile conditions within an operating room setting and requires proper sterilization and handling as per orthopedic implant protocols.

Other devices from Howmedica Corp.

See all devices from Howmedica Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of patients is the BG Proximal Femur designed to help, and how does it restore function?

    The BG Proximal Femur is intended for patients suffering from degenerative joint disease or hip fractures, where the natural femoral head and acetabulum have been damaged. It replaces these components in total hip arthroplasty to restore mobility and alleviate chronic pain by providing a stable, semi-constrained metal acetabular implant that mimics the natural hip joint’s movement.

  • Is the BG Proximal Femur reusable or single-use, and how should it be handled in the operating room?

    The BG Proximal Femur is designed as a reusable surgical implant, meaning it is intended for multiple uses after proper sterilization. Like all orthopedic implants, it must be handled in sterile conditions within the operating room and sterilized according to standard orthopedic implant protocols to ensure safety and prevent contamination.

  • What regulatory pathway was followed for FDA clearance, and what does the product code JDL indicate?

    The BG Proximal Femur received FDA clearance through a 510(k) submission (K790274), classified as a Class III medical device under product code JDL, which corresponds to ‘Prosthesis, Hip, Semi-Constrained (Metal Cemented Acetabular Component).’ The clearance was granted as *Substantially Equivalent (SESE)* to a predicate device, meaning it was determined to have the same intended use and technological characteristics as a previously approved product.

  • Are there multiple sizes or models available for the BG Proximal Femur, and how would a surgeon select the appropriate one?

    The BG Proximal Femur comes in multiple sizes and models, as indicated by the extensive list of FEI numbers (e.g., 3020282716, 3007923096) in the data. These identifiers correspond to specific implant dimensions and orientations to accommodate varying patient anatomies. Surgeons would select the appropriate size based on preoperative imaging and intraoperative assessment to ensure proper fit and function during total hip arthroplasty.